Reblozyl 75 MG vials
Ended Awarded
- Contract number
- SPE2DB25FWY37
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,673
Award facts
- Contract value 100% obligated
- $23,673.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $23,673.48 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Reblozyl 75 mg vials, a pharmaceutical product used in the treatment of certain blood disorders. This contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. The performance location is established at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. As a child order under a larger contract vehicle, this delivery order is executed through AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor serving federal medical procurement needs, leverages this IDC to supply pharmaceutical products and medical supplies to support military healthcare systems and the Defense Health Agency. The firm's federal contract portfolio demonstrates extensive experience fulfilling competitive awards for brand-name medications, generic drugs, and specialized medical commodities across multiple therapeutic domains. This delivery order represents a routine pharmaceutical supply transaction consistent with AmerisourceBergen's role as a critical vendor within the Defense Logistics Agency's medical supply chain operations.
Quick answers
Who was awarded contract SPE2DB25FWY37?
SPE2DB25FWY37 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 20, 2025.
How much is contract SPE2DB25FWY37 worth?
The government has obligated $23,673 on SPE2DB25FWY37.
Is contract SPE2DB25FWY37 an order under another contract?
Yes. SPE2DB25FWY37 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FWY37 competed?
The extent of competition for SPE2DB25FWY37 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award